Ataibeckley Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ataibeckley Inc. on June 3, 2026. The filing serves as a Regulation FD disclosure to announce the Company's participation in multiple investor conferences scheduled for June 2026. The Company is an emerging growth company incorporated in Delaware, with its common stock trading on the Nasdaq Global Market under the symbol "ATAI".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate events and does not contain financial statements or performance metrics.
Material Changes and Program Updates
Management indicated that upcoming conference presentations will include program updates, specifically the initiation of the BPL-003 Phase 3 pivotal ReConnection program. No other material changes to financial position or operations were disclosed in this specific filing.
Guidance, Outlook, and Risks
The Company plans to discuss development timelines and clinical trial progress at the following events:
- Jefferies Global Healthcare Conference: June 2–4, 2026, in New York, NY. Presentation on June 3 at 12:15 PM ET.
- Oppenheimer CNS and Neuro-Muscular Summit: June 10, 2026, in Miami, FL. Presentation on June 10 at 1:35 PM ET.
- 7th Annual HCW Neuro Perspectives Hybrid Conference: June 15–16, 2026, Virtual. Presentation on June 15 at 7:00 AM ET.
- UBS Virtual CNS Day: June 15, 2026, Virtual. Presentation on June 15 at 4:30 PM ET.
The filing includes standard forward-looking statements disclaiming guarantees regarding future results, noting that actual outcomes may differ due to risks detailed in the Company's most recent Form 10-K and Form 10-Q filings.
Investor Verification Checklist
- Verify the specific details and data regarding the BPL-003 Phase 3 ReConnection program during the announced conference presentations.
- Review the Company's most recent Form 10-K and Form 10-Q for comprehensive risk factors and financial status, as this 8-K does not contain such data.
- Confirm the availability of live webcasts and archived presentations via the Company's investor relations website.